Daniel Alber, MD (@dalber_) header
Daniel Alber, MD (@dalber_) profile picture

AI in Healthcare // Cardiothoracic Surgery Resident @stanfordctsurg // @nyugrossman and @BrownUniversity @BrownU_SwimDive alum // tweets my own

Manhattan, NY
Joined July 2018
Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)Photo by Daniel Alber, MD (@dalber_)
Excited to share our work, published with @SpringerNature @NatureMedicine exploring how we evaluate and verify the capabilities of #medical #AI systems with @ekoermann and colleagues @NYULangone @nyugrossman . Full paper at nature.com/articles/s41591-0…
3
2
2
34
5,181
🎉🫀Congratulations to four of our integrated residents—@KellyCHiga @AlexanderReedMD @GabeWeininger, and Jon Hochstein, MD—on receiving @NIH's highly competitive Ruth L. Kirschstein National Research Service Award F32 Postdoctoral Fellowship! ✨ Read more: ow.ly/lt5R50ZYxUI
3
1
18
2,874
Daniel Alber, MD retweeted
This is a good methodological thread on the debate over a new paper that suggests generalist models beat specialized medical AIs. (And a good overview of the challenges of benchmarking AIs in medicine)
Replying to @AdamRodmanMD
The TL;DR who don't want to sit through a virtual lab meeting with me: "This study provides directional data about the reference output quality of POC reference LLMs versus base models on actual reference inputs"
11
5
1
92
30,225
Daniel Alber, MD retweeted
There has ALREADY been a lot written about NYU @openevidence @UpToDate Expert AI study but wanted to give my perspective as what counts for an "expert" in human-computer interaction these days. Especially when I see Twitter debates about item response theory. 🤣 A 🧵⬇️
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated. @NatureMedicine nature.com/articles/s41591-0…
11
30
4
142
59,186
Daniel Alber, MD retweeted
And yet, Mayo Clinic is an investor in OpenEvidence. What's the old saying? People who live in glass houses shouldn't throw stones.
Rigorous evaluation of medical AI is good for everyone, and we welcome it. Counter to a half-dozen independent studies from institutions such as the Mayo Clinic that were highly positive on OpenEvidence—a lone paper now purports to show that generalized AI beats specialized clinical AI (@UpToDate, @openevidence). The paper has a massive undisclosed conflict of interest and irredeemable methodological flaws. Behind the scenes: The study authors run a competing in-house medical AI at their hospital, and asked OpenEvidence for an API to power it — including rights to build a "competing product" with OpenEvidence's own API. OpenEvidence declined. Then, this paper coincidentally appeared. Point-by-point, looking closely at the datasets used in the study, the disingenuous and fatal flaws become immediately apparent 🧵.
3
4
1
30
8,098
Daniel Alber, MD retweeted
There has been a push to use OpenEvidence AI for doctors. But this paper suggests general models are much better: “Frontier LLMs outperformed clinical AI tools in all three evaluations. Clinical AI tools performed comparably to auto-enabled Google Search AI Overview on the RCQ.”
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated. @NatureMedicine nature.com/articles/s41591-0…
40
46
8
425
74,631
Daniel Alber, MD retweeted
Medicine discovers the bitter lesson: frontier LLMs (here GPT 5.2, Opus 4.6, Gemini 3.1) outperform specialized "clinical AI" (e.g. OpenEvidence) in a blind test. Even funnier that hospital IT are more likely to approve the *specialized* versions despite them being worse.
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated. @NatureMedicine nature.com/articles/s41591-0…
29
160
22
1,145
188,208
Daniel Alber, MD retweeted
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated. @NatureMedicine nature.com/articles/s41591-0…
117
528
167
1,954
859,167
Daniel Alber, MD retweeted
Happy to report that our work on building foundation models for Cardiac MRI has finally been published in Nature Biomedical Engineering! @natBME nature.com/articles/s41551-0…
I’m excited to finally showcase our work on developing a generalizable deep learning system for cardiac MRI. This is the culmination of over 3 years of research spanning my time as a postdoc in @HiesingerLab and now as a cardiac surgery resident at @pennsurgery, and I couldn’t be happier with the finished product. Weights to be released for academic use (coming soon!). All built with @pytorch and @pytorch_lightning. Lots of really cool stuff to unpack, but here are few main results: Contrastive learning with cine-sequence CMR studies from multiple different views (short axis, 2-chamber, 3-chamber, and 4-chamber views) with long-form CMR free text reports is really hard. A good sign for us was how the video transformer embeddings evolved with each epoch. We train for about 600 epochs taking about 2 weeks. In a zero shot fashion, the model can then do some really interesting things: separate out different diseases (ACDC dataset), and different genders, age groups, and ejection fractions (UK BioBank) with no explicit supervised instruction. No such behaviour with kinetics-600 initialized weights (see preprint)! Finetuning over our system yields results superior to baseline approaches on downstream tasks of interest, with 10x and sometimes 100x less data. Here’s a quick figure showing how we achieve superior results for UK BioBank LVEF estimation with just 1% of the available data. Better yet, that same model when tested on a Kaggle dataset does exceptionally well (dashed line = kinetics-600 performance on left; lower is better!). Focusing on some disease diagnosis tasks, we label a separate dataset of some 6000 individual patients. This is real-world representative unenriched dataset. Our methods show massive improvements in AUC compared to baseline methods. Validation set shown here, internal test set (Stanford / Medstar / UCSF), and external test set (UPenn) figures are in the paper.
2
11
1
35
5,416
Hot off the press! ✨ New paper looking at a generalizable deep learning system for cardiac MRI🫀. Led by @StanfordMed @HiesingerLab researchers and collaborators.✨ @Penn @UCSF @rohanshad @cyrilzakka @dhamank24 @mrudangm14 @StanfordDeptMed @StanfordVasc ow.ly/L6UE50YyOiy
3
7
675
Daniel Alber, MD retweeted
I wrote an app using Google AI Studio that calculates how much oversized or undersized a TAVR valve is based on native valve area or perimeter. I know nothing about coding.
1
10
5
121
14,364
Daniel Alber, MD retweeted
Beyond thrilled to match at @ColumbiaCTSurg for Cardiothoracic Surgery!! This is an absolute dream come true, and I am so grateful for all my mentors who have supported me on this journey! @ArnarGeirssonMD @mori_md @MarcPPelletier @YaleCardiacSurg
20
17
1
217
7,222
Daniel Alber, MD retweeted
Over the moon to be heading west to Seattle to join the @UWCTSurgRes family! Grateful to my mentors @karamlou and @Dr_HaniNajm for fostering my passion for cardiothoracic surgery and for the privilege of caring for these patients.
19
11
1
168
6,589
Daniel Alber, MD retweeted
An absolute dream come true! I couldn't imagine a better team or place to train with! Unbelievably grateful and excited! @pennsurgery #MatchDay2026 ❤️🫀
16
17
2
369
11,057
Daniel Alber, MD retweeted
Mom I’m going to be a heart surgeon! @UscCardiac back to LA I go! Unbelievable.
29
49
1
968
17,425
Honored to be joining the team @stanfordctsurg!
✨Congrats to our incoming @StanfordCTSurg integrated residents! 🎉 We're excited to have three new interns joining our program: Daniel Alber of @nyugrossman, Oluwademilade Tega of @ColumbiaPS, and Brandon Wesley of @StanfordMed - welcome to the team!🌲#WeAreStanford #Match2026
3
5
1
89
6,844
✨Congrats to our incoming @StanfordCTSurg integrated residents! 🎉 We're excited to have three new interns joining our program: Daniel Alber of @nyugrossman, Oluwademilade Tega of @ColumbiaPS, and Brandon Wesley of @StanfordMed - welcome to the team!🌲#WeAreStanford #Match2026
10
4
93
9,576
At @nyulangone @nyugrossman, we get to build real-world healthcare AI from the ground up! Awesome work by the brilliant @lavenderjiang99 @ekoermann.
We built Lang1: a 100M–7B family of models specialized for hospital operations. After finetuning, Lang1-1B outperforms generalist models up to 671B, transfers to unseen tasks and another hospital, and is more data-efficient. 🧵Why small specialists win in healthcare.
2
328
#EditorsChoice This study performed left ventricular outflow tract modification in patients with an increased risk of systolic anterior motion. Read the results from Loulmet, Grossi, and coauthors👇 doi.org/10.1016/j.athoracsur… #VisualAbstract
3
8
1,675
Great paper by @kgrace_phil & co @nyulangone. State of the art review of cardiac xenotransplant.
This review explores the current advancements in xenotransplantation, ongoing challenges, and discuss its future potential in addressing the growing demand for donor organs in cardiac transplantation. @kgrace_phil @NYULangone @PedsLiverTxp @DanielWolbrom ahajournals.org/doi/full/10.…
4
15
2,131
Daniel Alber, MD retweeted
This review explores the current advancements in xenotransplantation, ongoing challenges, and discuss its future potential in addressing the growing demand for donor organs in cardiac transplantation. @kgrace_phil @NYULangone @PedsLiverTxp @DanielWolbrom ahajournals.org/doi/full/10.…
2
15
3
42
8,417